[1] Jornet P.L, Garcia F.J, Berdugo M.L, Perez F.P. and Lopez A.P. Mouth self-examination in a population at risk of oral cancer Australian Dental Journal, 60 (2015), pp. 59-64.
[2] Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer, 127 (2010), pp. 2893-2917.
[3] Lo W.L, Kao S.Y, Chi L.Y, Wong Y.K. and Chang R.C. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons, 61 (2003), pp. 751-758.
[4] Timothy P.J.Liu, Bradley M.Fisher, Benjamin Chua, et al. Survival outcomes following modern multidisciplinary management of oral squamous cell carcinoma in Australia Oral Radiology, 131(2021), pp.92-98.
[5] Maehama T. & Dixon J. E. PTEN: a tumour suppressor that functions as a phospholipid phosphatase Trends Cell Biol, 9 (1999), pp.125-128.
[6] Bonneau D. & Longy M. Mutations of the human PTEN gene Hum Mutat, 16, (2000), pp.109-122.
[7] Mavros A, Hahn M, Wieland I, et al. Infrequent geneticalterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity J Oral Pathol Med, 31(2002), pp.270-276.
[8] Georgescu M.M. PTEN tumor suppressor network in PI3K-AKT path-way control Genes Cancer, 1(2010), pp.1170–1177.
[9] Michael A. Davies Reguration, Role, and Targeting of Akt in Cancer Journal of Clinical Oncology, 29(2011), pp.4715-4717.
[10] Brodersen P and Voinnet O. Revisiting the principles of microRNA target recognition and mode of action Nat Rev Mol Cell Biol, 10(2009), pp.141-148.
[11] A Helwak, G Kudla, T Dudnakova, D Tollervey. Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding Cell, 153(2013), pp 654-665.
[12] La Torre. A, Georgi S, Reh T.A. Conserved microRNA pathway regulates developmental timing of retinal neurogenesis Proc. Natl. Acad. Sci. U. S. A. , 110(2013), pp.2362-2370.
[13] Le M.T.N, Xie H, Zhou B, Chia P.H, Rizk P, Um M, Udolph G, Yang H, Lim B, Lodish H.F. MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets Mol. Cell. Biol, 29(2009), pp.5290-5305.
[14] Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis Nature, 436(2005), pp.214-20.
[15] Körner C, Keklikoglou I, Bender C, Wörner A, Münstermann E, Wiemann S. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCepsilon) J. Biol. Chem, 288(2013), pp.8750-8761.
[16] Chen Y.H, Song Y, Yu Y.L, Cheng W, Tong X. MiRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism Oncol Lett, 17(2019), pp.5441-5446.
[17] He B, Lin X, Tian F, Yu W, Qiao B. MiR-133a-3p inhibits oral squamous cell carcinoma (OSCC) proliferation and invasion by suppressing COL1A1 J Cell Biochem, 119(2018), pp.338-346.
[18] Islam F, Gopalan V, Vider J, Lu C.T, Lam A.K. MiR-142-5p act as an oncogenic microRNA in colorectal cancer: clinicopathological and functional insights Exp Mol Pathol, 104(2018), pp.98-107.
[19] Liu L, Liu S, Duan Q, et al. MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3 Am J Transl Res, 9(2017), pp.2394-2402.
[20] Junlian G, Tian T, et al. Overexpression of MicroRNA 142-5p Suppresses the Progression of Cervical Cancer through Targeting Phosphoinositol-3-Kinase Adaptor Protein 1 Expression Molecular and cellular biology, 41(2021), pp.363-383.
[21] W. Xu, W. Wang. MicroRNA-142-5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog Mol Mel Rep, 17(2018), pp.7529-7536.
[22] Bai X, Zhou Y, Chen P, Yang M, Xu, J. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN Journal of Cellular Biochemistry, 119(2018), pp.2179-2188.
[23] KJ Livak, TD schmittgen. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2⁻ΔΔCT Method Methods, 25(2001), pp 402-408.
[24] Baba O, Hasegawa S, Nagai H, Uchida F, Yamatoji M, Kanno NI, Yamagata K, Sakai S, Yanagawa T and Bukawa H. MicroRNA155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis J Oral Pathol, 45(2016), pp.248-255.
[25] Nagai H, Hasegawa S, Uchida F, Terabe T, Ishibashi Kanno N, Kato K, Yamagata K, Sakai S, Kawashiri S, Sato H, Yanagawa T, Bukawa H. MicroRNA-205-5p suppresses the invasiveness of oral squamous cell carcinoma by inhibiting TIMP-2 expression Int J Oncol, 52(2018), pp.841-850.
[26] YH Huang, HC Kuo, YL Yang, FS Wang. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation International Journal of Medical Sciences, 16(2019), pp 212-220.
[27] Lee G.Y, Kenny P.A, Lee E.H and Bissell M.J. Three-dimensional culture models of normal and malignant breast epithelial cells Nat Methods, 4(2007), pp.359-365.
[28] Sakr M, Takino T, Sabit H, Nakada M, Li Z and Sato H. MiR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase Gene, 587(2016), pp.155-162.
[29] Richard W. Carthew, Erik J. Sontheimer. Origins and Mechanisms of miRNAs and siRNAs Cell, 136(2009), pp.642-655.
[30] Lim L.P, Lau N.C, Garrett-Engele P, Grimson A, Schelter J.M, Castle J, Bartel D.P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature, 433(2005), pp.769-773.
[31] Carmen Sucharova, Michael R. Bristowa, J. David Port. MiRNA expression in the failing human heart: Functional correlates Journal of Molecular and Cellular Cardiology, 45(2008), pp.185-192.
[32] Kim A. Lennox, Mark A. Behlke. A Direct Comparison of Anti-microRNA Oligonucleotide Potency Pharmaceutical Research, 27(2010), pp.1788-1799.
[33] Pahini P, Jose L, et al. Modes of invasion during tumour dissemination Molecular Oncology, 11(2017), pp 5-27.
[34] Jiang X.M, Yu X.N, Liu T.T, Zhu H.R, Shi X, Bilegsaikhan E, Guo H.Y, Song G.Q, Weng S.Q, Huang X.X, et al. MicroRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma Biomed Pharmacother, 105(2018), PP.1147-1154.
[35] Li J, Liu X, Li C, Wang W. MiR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma J Cell Biochem, 120(2019), pp.12412–12421.
[36] Kurasawa Y, Shiiba M, et al. PTEN expression and methylation status in oral squamous cell carcinoma Oncology Reports, 19(2008), pp 1429-1434.
[37] X. Wan, L.J Helman. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-IIoverexpressing rhabdomyosarcomas cells Oncogene, 22(2003), pp.8205-8211.
[38] Lee M. S, Jeong M. H, Lee H. W, Han H. J, Ko A, Hewitt S.M, Kim J. H, Chun K. H, Chung J. Y, Lee C. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis Nat. Commun, 6(2015), pp.7769.
[39] L LI, X ZHU, T SHOU, L YANG, et al. MicroRNA‑28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway Molecular Medicine Reports, 17(2018), pp 4003-4010.
[40] JH JIANG, QY LV, YX YI, J LIAO, et al. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN European Review for Medical and Pharmacological Sciences 22(2018), pp 6260-6267
[41] Q Wang, L LV, Y LI, H JI. MicroRNA‑655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway Molecular Medicine Reports, 18(2018), pp 3106-3114.
[42] Y Cohen , B Shalmon, et al. Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma Oral Oncology, 47(2011), pp 946-950.
[43] P S Sushma , Kaiser, et al. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population Tumour Biology, 37(2016), pp 2625-2632.
[44] M Miella, I Falcone, et al. PTEN: multiple functions in human malignant tumors Frontiers in Oncology, 16(2015), https://doi.org/10.3389/fonc.2015.00024